OTCMKTS:AMAR Amarillo Biosciences (AMAR) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Amarillo Biosciences Stock (OTCMKTS:AMAR) Get Amarillo Biosciences alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume6,100 shsAverage Volume18,253 shsMarket Capitalization$25.24 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Amarillo Biosciences, Inc. is a biotechnology company focused on developing biological products for human and animal health applications. Its research has centered primarily on low-dose oral interferon alpha, a cytokine intended to support immune responses and address certain viral and other medical conditions. The company has investigated oral interferon alpha for potential uses including respiratory infections, hepatitis, HIV-related conditions, and veterinary applications. Amarillo Biosciences has also explored partnerships and licensing opportunities to advance the development and commercialization of its products. Founded in 1984 and based in Amarillo, Texas, the company has historically operated as a development-stage biotechnology business. Information regarding its current commercial operations, product availability, geographic reach, and leadership is limited.AI Generated. May Contain Errors. Read More Receive AMAR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amarillo Biosciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AMAR Stock News HeadlinesAmarillo native earns Rising Star awardJune 26, 2025 | msn.comAmarillo native, Navy veteran earns Rising Star Award for leadership in electric vehicle sectorJune 26, 2025 | msn.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.September 21 at 1:00 AM | Porter & Company (Ad)Vikings Acquire RB Cam Akers in Midseason Trade With TexansOctober 17, 2024 | msn.comFrance’s divided National Assembly votes to keep centrist speaker as political turmoil persistsJuly 20, 2024 | msn.comAmarillo, United States - Weather Forecasts | Maps | News - Yahoo WeatherMay 7, 2024 | yahoo.comTexas Rising Stars award honors two Amarillo lawyersApril 2, 2024 | msn.comRising Stars attorneys, Midland wildfire donations among this week's business newsMarch 31, 2024 | msn.comSee More Headlines AMAR Stock Analysis - Frequently Asked Questions How were Amarillo Biosciences' earnings last quarter? Amarillo Biosciences, Inc. (OTCMKTS:AMAR) issued its earnings results on Wednesday, November, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $0.02 million for the quarter. How do I buy shares of Amarillo Biosciences? Shares of AMAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Amarillo Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Amarillo Biosciences investors own include Fulcrum Therapeutics (FULC), Cerecor (CERC), AquaBounty Technologies (AQB), Astria Therapeutics (ATXS) and Company Calendar Last Earnings11/14/2018Today9/21/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorTechnology Industry Technology Hardware, Storage & Peripherals Sub-IndustryTechnology Hardware, Storage & Peripherals Current SymbolOTCMKTS:AMAR CIK1014763 Webwww.amarbio.com Phone806-376-1741FaxN/AEmployees2Year Founded1984Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$1.45 million Net Margins-41,453.98% Pretax MarginN/A Return on EquityN/A Return on Assets-574.29% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.07 Sales & Book Value Annual Sales$20 thousand Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / BookN/AMiscellaneous Outstanding Shares42,066,000Free FloatN/AMarket Cap$25.24 million OptionableNot Optionable Beta-0.06 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (OTCMKTS:AMAR) was last updated on 9/21/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amarillo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amarillo Biosciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMAR Stock Alerts